The Venous Center

Filter Your Results




SVS Encourages More Participation in PRESERVE Study of IVC Filters

November 8, 2016 -- The Society for Vascular Surgery (SVS) recently announced updated information on enrollment in the PRESERVE (Predicting the Safety and Effectiveness of Inf…

Two Real-World Studies Evaluate Xarelto in Treating VTE

October 23, 2016 -- Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, announced results of two real-world studies confirming the benefit-risk profil…

FDA Clears Teleflex's Arrow Midline With Chloragard Technology

October 17, 2016 -- Teleflex Incorporated announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its Arrow Midline with Chloragard tec…

Final 2-Year Data Published for Bard’s DENALI IVC Filter Trial

October 5, 2016 -- An analysis of the final DENALI trial data was published by S. William Stavropoulos, MD, et al in the Journal of Vascular and Interventional Radiology (JVIR…

Bio2 Announces Commercial Launch of the Angel Catheter in the United States

October 5, 2016 -- Bio2 Medical announced the commercial launch of the Angel catheter in the United States. In August, Bio2 announced that the Angel catheter receive…

Vascular Solutions Issues Recall of Twin-Pass Dual Access Catheters

October 5, 2016 -- Vascular Solutions, Inc. announced that the company voluntarily initiated a nationwide recall of its Twin-Pass Dual Access catheters through an Urgent Medic…

BOLSTER Data Presented for Bard’s LifeStream Balloon-Expandable Covered Stent

September 21, 2016 -- John Laird, MD, presented 9-month data from the BOLSTER trial during the third Late-Breaking Trials session at VIVA 16, the 14th annual Vascular InterVen…

An Interview With Peter Gloviczki, MD, FACS

September 2016— How would you summarize the purpose of the Venous MEDCAC panel that took place in July 2016? The purpose of the meeting was to convene a panel to advise the Center…



2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.